No Data
No Data
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading
European equities traded in the US as American depositary receipts were moving sharply higher late Wednesday morning, rising 1.59% to 1,445.87 on the S&P Europe Select ADR Index. From continental Euro
European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Tuesday Trading
European equities traded in the US as American depositary receipts were trending sharply lower late Tuesday morning, falling 1.34% to 1,420.05 on the S&P Europe Select ADR Index. From continental Euro
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
European equities traded in the US as American depositary receipts were higher Wednesday morning, rising 0.93% to 1,436.34 on the S&P Europe Select ADR Index. From continental Europe, the gainers were
Ascendis Pharma to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
COPENHAGEN, Denmark, June 04, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (NASDAQ:ASND) today announced that company executives will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare
Ascendis Pharma Reports 45% Clinical Response in TransCon IL-2 Phase 1/2 Trial
Ascendis Pharma (ASND) said Monday that 45% of patients with locally advanced or metastatic solid tumors getting TransCon IL-2 every three weeks in the phase 1/2 clinical trial showed clinical respons
Ascendis Pharma Presents New Data and Updated Results From Phase 1/2 IL-Believe Trial at ASCO 2024
Ascendis Pharma A/S (Nasdaq: ASND) reported new and updated results from its ongoing Phase 1/2 IL-Believe Trial of TransCon IL-2 β⁄γ in a poster presentation at ASCO 2024, the annual meeting of the American Society of Clinical Oncology being held in Chicago May 31–June 4, 2024.